Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Security National Financial
SNFCA
$242M
| $1.85M | ﹤0.01% |
237,780
-3,473
| -1% | -$23.9K |
|
2002
OneSpan
OSPN
$602M
| $1.85M | ﹤0.01% |
172,282
+70,712
| +70% | +$694K |
|
2003
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.3B
| $1.84M | ﹤0.01% |
79,600
+34,200
| +75% | +$747K |
|
2004
Anterix
ATEX
$1.79B
| $1.84M | ﹤0.01% |
55,200
-13,700
| -20% | -$442K |
|
|
KC
2005
Kingsoft Cloud Holdings
KC
$3.51B
| $1.84M | ﹤0.01% |
486,600
-101,200
| -17% | -$462K |
|
2006
AMN Healthcare
AMN
$1.34B
| $1.83M | ﹤0.01% |
24,500
-188,732
| -89% | -$13.5M |
|
|
STCN
2007
DELISTED
Steel Connect, Inc. Common Stock
STCN
| $1.83M | ﹤0.01% |
190,443
-3,715
| -2% | -$36.2K |
|
2008
Aclaris Therapeutics
ACRS
$851M
| $1.83M | ﹤0.01% |
1,746,432
+1,098,780
| +170% | +$3.35M |
|
2009
iShares Global Healthcare ETF
IXJ
$4.2B
| $1.83M | ﹤0.01% |
+21,100
| New | +$1.75M |
|
2010
iShares MSCI Taiwan ETF
EWT
$11.5B
| $1.83M | ﹤0.01% |
+39,700
| New | +$1.84M |
|
2011
abrdn Physical Palladium Shares ETF
PALL
$651M
| $1.82M | ﹤0.01% |
90,225
+48,725
| +117% | +$982K |
|
2012
JELD-WEN Holding
JELD
$167M
| $1.82M | ﹤0.01% |
96,400
-132,800
| -58% | -$1.97M |
|
2013
Enpro
NPO
$7.27B
| $1.82M | ﹤0.01% |
11,600
-19,557
| -63% | -$2.53M |
|
2014
iShares Russell 3000 ETF
IWV
$20.5B
| $1.81M | ﹤0.01% |
6,600
+900
| +16% | +$229K |
|
|
SSBK
2015
DELISTED
Southern States Bancshares
SSBK
| $1.81M | ﹤0.01% |
61,692
+43,029
| +231% | +$1.07M |
|
|
TGI
2016
DELISTED
Triumph Group
TGI
| $1.8M | ﹤0.01% |
108,700
-511,600
| -82% | -$5.19M |
|
2017
Praxis Precision Medicines
PRAX
$10.2B
| $1.8M | ﹤0.01% |
80,804
+15,671
| +24% | +$282K |
|
2018
Outset Medical
OM
$84.8M
| $1.8M | ﹤0.01% |
22,160
+14,227
| +179% | +$1.16M |
|
2019
InvenTrust Properties
IVT
$2.62B
| $1.79M | ﹤0.01% |
70,800
+44,100
| +165% | +$1.1M |
|
2020
The Honest Company
HNST
$519M
| $1.79M | ﹤0.01% |
543,000
+119,700
| +28% | +$218K |
|
2021
iHeartMedia
IHRT
$457M
| $1.79M | ﹤0.01% |
670,727
+147,500
| +28% | +$373K |
|
2022
uniQure
QURE
$3.37B
| $1.79M | ﹤0.01% |
264,513
-184,599
| -41% | -$1.22M |
|
2023
loanDepot
LDI
$303M
| $1.79M | ﹤0.01% |
508,400
-1,700
| -0.3% | -$3.2K |
|
|
PDS
2024
Precision Drilling
PDS
$1.09B
| $1.79M | ﹤0.01% |
32,800
+28,300
| +629% | +$1.63M |
|
2025
Universal Electronics
UEIC
$67.9M
| $1.79M | ﹤0.01% |
190,223
+36,200
| +24% | +$296K |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.